409 related articles for article (PubMed ID: 26270620)
1. Prolonged antibiotics for non-cystic fibrosis bronchiectasis in children and adults.
Hnin K; Nguyen C; Carson KV; Evans DJ; Greenstone M; Smith BJ
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD001392. PubMed ID: 26270620
[TBL] [Abstract][Full Text] [Related]
2. Prolonged antibiotics for purulent bronchiectasis in children and adults.
Evans DJ; Bara AI; Greenstone M
Cochrane Database Syst Rev; 2007 Apr; (2):CD001392. PubMed ID: 17443506
[TBL] [Abstract][Full Text] [Related]
3. Prolonged antibiotics for purulent bronchiectasis.
Evans DJ; Bara AI; Greenstone M
Cochrane Database Syst Rev; 2003; (4):CD001392. PubMed ID: 14583934
[TBL] [Abstract][Full Text] [Related]
4. Macrolide antibiotics for bronchiectasis.
Kelly C; Chalmers JD; Crossingham I; Relph N; Felix LM; Evans DJ; Milan SJ; Spencer S
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012406. PubMed ID: 29543980
[TBL] [Abstract][Full Text] [Related]
5. Intermittent prophylactic antibiotics for bronchiectasis.
Spencer S; Donovan T; Chalmers JD; Mathioudakis AG; McDonnell MJ; Tsang A; Leadbetter P
Cochrane Database Syst Rev; 2022 Jan; 1(1):CD013254. PubMed ID: 34985761
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Dual antibiotics for bronchiectasis.
Felix LM; Grundy S; Milan SJ; Armstrong R; Harrison H; Lynes D; Spencer S
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012514. PubMed ID: 29889304
[TBL] [Abstract][Full Text] [Related]
8. Antibiotics for exacerbations of asthma.
Normansell R; Sayer B; Waterson S; Dennett EJ; Del Forno M; Dunleavy A
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD002741. PubMed ID: 29938789
[TBL] [Abstract][Full Text] [Related]
9. Head-to-head trials of antibiotics for bronchiectasis.
Kaehne A; Milan SJ; Felix LM; Sheridan E; Marsden PA; Spencer S
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD012590. PubMed ID: 30184243
[TBL] [Abstract][Full Text] [Related]
10. The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis.
Laska IF; Crichton ML; Shoemark A; Chalmers JD
Lancet Respir Med; 2019 Oct; 7(10):855-869. PubMed ID: 31405826
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Normansell R; Maisey S; Poole P
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009764. PubMed ID: 30376188
[TBL] [Abstract][Full Text] [Related]
12. Adverse events in people taking macrolide antibiotics versus placebo for any indication.
Hansen MP; Scott AM; McCullough A; Thorning S; Aronson JK; Beller EM; Glasziou PP; Hoffmann TC; Clark J; Del Mar CB
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD011825. PubMed ID: 30656650
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
Langton Hewer SC; Smyth AR
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD004197. PubMed ID: 28440853
[TBL] [Abstract][Full Text] [Related]
14. Exercise training for bronchiectasis.
Lee AL; Gordon CS; Osadnik CR
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013110. PubMed ID: 33822364
[TBL] [Abstract][Full Text] [Related]
15. Self-management for bronchiectasis.
Kelly C; Grundy S; Lynes D; Evans DJ; Gudur S; Milan SJ; Spencer S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD012528. PubMed ID: 29411860
[TBL] [Abstract][Full Text] [Related]
16. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
Skilton M; Krishan A; Patel S; Sinha IP; Southern KW
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009841. PubMed ID: 30616300
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
Langton Hewer SC; Smyth AR
Cochrane Database Syst Rev; 2014 Nov; (11):CD004197. PubMed ID: 25383937
[TBL] [Abstract][Full Text] [Related]
18. Inhaled hyperosmolar agents for bronchiectasis.
Hart A; Sugumar K; Milan SJ; Fowler SJ; Crossingham I
Cochrane Database Syst Rev; 2014 May; 2014(5):CD002996. PubMed ID: 24817558
[TBL] [Abstract][Full Text] [Related]
19. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
Vollenweider DJ; Frei A; Steurer-Stey CA; Garcia-Aymerich J; Puhan MA
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD010257. PubMed ID: 30371937
[TBL] [Abstract][Full Text] [Related]
20. Interventions to reduce Staphylococcus aureus in the management of eczema.
George SM; Karanovic S; Harrison DA; Rani A; Birnie AJ; Bath-Hextall FJ; Ravenscroft JC; Williams HC
Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
